Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Chemical industry innovation is unevenly distributed
Dow-DuPont merger may result in bidding for stranded R&D capability
by Melody M. Bomgardner
March 7, 2016
| A version of this story appeared in
Volume 94, Issue 10
A two-way analysis of innovation and business acumen at leading specialty chemical and materials firms shows considerable variation in companies’ abilities to create—and profit from—new and differentiated products.
The competitive benchmark, developed by market research firm Lux Research, also illuminates the landscape for future deals that may spring from the merger of Dow Chemical and DuPont.
Within the Lux matrix, DuPont scored significantly higher than Dow on the innovation scale. Accordingly, says Lux analyst Brent Giles, Dow’s agriculture business will be strengthened by DuPont’s ag research abilities when the two businesses come together.
In contrast, DuPont’s industry-leading industrial biotech know-how will likely be a poor fit for the DowDuPont specialty products company. This “stranded” innovation capacity will be a ripe target for acquisition by other companies, Giles suggests.
Source: Lux Research
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X